Anastrozole and Primobolan Interaction: Compatible | Peptide Database

Join others researching Liothyronine (T3) — share findings, ask questions, and learn from real experiences Liothyronine (T3) is the biologically active form of thyroid hormone, responsible for regulating basal metabolic rate, thermogenesis, protein synthesis, and cellular energy metabolism throughout the body. Unlike levothyroxine (T4), which serves primarily as a prohormone requiring peripheral conversion by deiodinase enzymes, T3 acts directly on nuclear thyroid hormone receptors to exert its metabolic effects. It has been FDA-approved since the 1950s for the treatment of hypothyroidism, myxedema coma, and as a diagnostic agent in thyroid suppression tests. Pharmaceutical T3 is available as Cytomel (brand) and generic liothyronine sodium tablets. In performance and biohacking contexts, T3 is widely used during cutting phases to accelerate fat loss by directly upregulating metabolic rate, and by individuals seeking metabolic optimization when peripheral T4-to-T3 conversion is impaired due to caloric restriction, stress, or other factors. Liothyronine enters target cells via monocarboxylate transporter 8 (MCT8) and other thyroid hormone transporters, then binds to nuclear thyroid hormone receptors (primarily TR-beta in metabolic tissues and TR-alpha in cardiac tissue). The T3-receptor complex forms heterodimers with retinoid X receptors (RXR) and binds to thyroid hormone response elements (TREs) on DNA, directly modulating gene transcription. This increases expression of Na+/K+ ATPase (driving cellular energy expenditure), uncoupling proteins (UCP1 in brown adipose tissue, promoting thermogenesis), and enzymes involved in fatty acid oxidation, gluconeogenesis, and protein turnover. T3 also upregulates beta-adrenergic receptor density, which amplifies catecholamine sensitivity and contributes to increased heart rate, lipolysis, and thermogenesis. At physiological doses, T3 supports healthy metabolism; at supraphysiological doses, it shifts the body into a catabolic state where both fat and lean tissue can be catabolized for energy.

VIP inhalation shows striking efficacy with increased mixed venous oxygen saturation and exercise capacity. Dilates peripheral blood vessels through NO-dependent mechanisms above 100 pmol doses. Coronary vasodilation with positive inotropic and chronotropic effects on the heart. Promising therapeutic target for Alzheimer's, Parkinson's, and other neurological disorders. Potential therapeutic target being researched for ASD. Produced in suprachiasmatic nuclei; involved in circadian regulation. Promotes insulin secretion in glucose-dependent manner via VPAC2; low hypoglycemia risk. Potent anti-inflammatory effects useful in IBD and autoimmune conditions. Therapeutic potential for pulmonary and systemic sarcoidosis.